Literature DB >> 25459350

Mining cancer gene expression databases for latent information on intronic microRNAs.

Simona Monterisi1, Giovanni D'Ario1, Elisa Dama2, Nicole Rotmensz3, Stefano Confalonieri4, Chiara Tordonato1, Flavia Troglio1, Giovanni Bertalot1, Patrick Maisonneuve3, Giuseppe Viale5, Francesco Nicassio6, Manuela Vecchi4, Pier Paolo Di Fiore7, Fabrizio Bianchi8.   

Abstract

Around 50% of all human microRNAs reside within introns of coding genes and are usually co-transcribed. Gene expression datasets, therefore, should contain a wealth of miRNA-relevant latent information, exploitable for many basic and translational research aims. The present study was undertaken to investigate this possibility. We developed an in silico approach to identify intronic-miRNAs relevant to breast cancer, using public gene expression datasets. This led to the identification of a miRNA signature for aggressive breast cancer, and to the characterization of novel roles of selected miRNAs in cancer-related biological phenotypes. Unexpectedly, in a number of cases, expression regulation of the intronic-miRNA was more relevant than the expression of their host gene. These results provide a proof of principle for the validity of our intronic miRNA mining strategy, which we envision can be applied not only to cancer research, but also to other biological and biomedical fields.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer; Gene expression; MicroRNA

Mesh:

Substances:

Year:  2014        PMID: 25459350      PMCID: PMC5528658          DOI: 10.1016/j.molonc.2014.10.001

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  58 in total

1.  Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.

Authors:  Stefano Volinia; Marco Galasso; Maria Elena Sana; Timothy F Wise; Jeff Palatini; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

Review 2.  Annotating noncoding RNA genes.

Authors:  Sam Griffiths-Jones
Journal:  Annu Rev Genomics Hum Genet       Date:  2007       Impact factor: 8.929

3.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 4.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

5.  Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair.

Authors:  Libing Song; Ting Dai; Yingjun Xie; Chanjuan Wang; Chuyong Lin; Zhiqiang Wu; Zhe Ying; Jueheng Wu; Mengfeng Li; Jun Li
Journal:  J Mol Cell Biol       Date:  2011-12-08       Impact factor: 6.216

6.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.

Authors:  Andy J Minn; Yibin Kang; Inna Serganova; Gaorav P Gupta; Dilip D Giri; Mikhail Doubrovin; Vladimir Ponomarev; William L Gerald; Ronald Blasberg; Joan Massagué
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

7.  An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.

Authors:  Alejandro Sweet-Cordero; Sayan Mukherjee; Aravind Subramanian; Han You; Jeffrey J Roix; Christine Ladd-Acosta; Jill Mesirov; Todd R Golub; Tyler Jacks
Journal:  Nat Genet       Date:  2004-12-19       Impact factor: 38.330

8.  Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Authors:  Christos Sotiriou; Pratyaksha Wirapati; Sherene Loi; Adrian Harris; Steve Fox; Johanna Smeds; Hans Nordgren; Pierre Farmer; Viviane Praz; Benjamin Haibe-Kains; Christine Desmedt; Denis Larsimont; Fatima Cardoso; Hans Peterse; Dimitry Nuyten; Marc Buyse; Marc J Van de Vijver; Jonas Bergh; Martine Piccart; Mauro Delorenzi
Journal:  J Natl Cancer Inst       Date:  2006-02-15       Impact factor: 13.506

9.  Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.

Authors:  W M Grady; R K Parkin; P S Mitchell; J H Lee; Y-H Kim; K D Tsuchiya; M K Washington; C Paraskeva; J K V Willson; A M Kaz; E M Kroh; A Allen; B R Fritz; S D Markowitz; M Tewari
Journal:  Oncogene       Date:  2008-02-11       Impact factor: 9.867

10.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.

Authors:  Cherie Blenkiron; Leonard D Goldstein; Natalie P Thorne; Inmaculada Spiteri; Suet-Feung Chin; Mark J Dunning; Nuno L Barbosa-Morais; Andrew E Teschendorff; Andrew R Green; Ian O Ellis; Simon Tavaré; Carlos Caldas; Eric A Miska
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  3 in total

1.  Expression, regulation and function of miR-495 in healthy and tumor tissues.

Authors:  Hongli Chen; Xiaman Wang; Ju Bai; Aili He
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

2.  Identification of four hub genes associated with adrenocortical carcinoma progression by WGCNA.

Authors:  Wang-Xiao Xia; Qin Yu; Gong-Hua Li; Yao-Wen Liu; Fu-Hui Xiao; Li-Qin Yang; Zia Ur Rahman; Hao-Tian Wang; Qing-Peng Kong
Journal:  PeerJ       Date:  2019-03-14       Impact factor: 2.984

3.  Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients.

Authors:  Aikaterini F Giannopoulou; Eumorphia G Konstantakou; Athanassios D Velentzas; Socratis N Avgeris; Margaritis Avgeris; Nikos C Papandreou; Ilianna Zoi; Vicky Filippa; Stamatia Katarachia; Antonis D Lampidonis; Anastasia Prombona; Popi Syntichaki; Christina Piperi; Efthimia K Basdra; Vassiliki Iconomidou; Evangelia Papadavid; Ema Anastasiadou; Issidora S Papassideri; Athanasios G Papavassiliou; Gerassimos E Voutsinas; Andreas Scorilas; Dimitrios J Stravopodis
Journal:  Int J Mol Sci       Date:  2019-02-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.